NuvaRing is a fairly new birth control method for women; it is a small flexible contraceptive ring about the size of a silver dollar. NuvaRing contains the same hormones as many birth control pills and is inserted into the vagina, where it stays for three weeks. Once inserted, there is a continuous low dose of hormones being released. The ring is then removed for one week, and that is the week women will have their period.

NuvaRing was approved by the FDA in October 2001 and has been linked to blood clots in women. In December 2007, the American Society of Hematology reported three cases of women who developed complications including blood clots while using the ring.
Side effects include:

Heart attacks
Myocardial infarction
Stroke
Blood clotting
Pulmonary embolism
Death

Our Nuvaring injury lawyers have concluded that the high number of injuries associated with Nuvaring is the result of a dangerous type of hormone emitted by the device. The use of this hormone makes NuvaRing one of the most dangerous contraceptives on the market.

In 2007, the consumer advocacy group Public Citizen asked the FDA to ban oral contraceptives that contained forms of desogestral because this dangerous progestin has been implicated in a higher risk of strokes, blood clots and other cardiovascular problems. NuvaRing releases approximately 120 micrograms of etonogestral – an active desogestral metabolite – per day, a relatively high dose of this dangerous hormone. The NuvaRing injury lawyers at our firm believe this high dose of etonogestral is responsible for the high number of cardiac side effects reports associated with NuvaRing.

If you have used NuvaRing for birth control in the Chicago area, please contact the Law Offices of Barry G. Doyle, P.C. today to schedule your initial appointment.